关颅时颅内压是创伤性急性硬膜下血肿手术减压充分性的客观术中决定因素:一项多中心观察性研究
该多中心回顾性研究纳入105例接受减压手术的急性硬膜下血肿患者,通过ROC分析确定关颅时颅内压阈值为10 mmHg(特异性91.5%,敏感性45.7%),并将患者分为减压不充分组(26例)和良好组(79例)。调整后,不充分组术后甘露醇使用(OR 14.2)、巴比妥类使用(OR 150)、住院死亡率(OR 24.9)均升高,1年良好MRS率降低(OR 0.08),并发症率相似。作者认为关颅时颅内压是与结局相关的客观术中生物标志物,建议大规模前瞻性研究验证该阈值。
要点
- 关颅时颅内压阈值10 mmHg用于区分减压不充分与良好(特异性91.5%,敏感性45.7%)。
- 减压不充分组术后甘露醇使用OR 14.2、巴比妥类使用OR 150,均高于良好组。
- 减压不充分组住院死亡率OR 24.9,1年良好MRS率OR 0.08,并发症率两组相似。
核心结论
- 关颅时颅内压是一种新颖、客观、可操作的术中生物标志物,与急性硬膜下血肿患者的住院和长期结局相关。
- 可采取多种手术操作安全达到该目标。
- 应开展大规模前瞻性研究验证该颅内压阈值。
研究设计与样本
- 多中心回顾性综述,纳入105例连续接受减压手术的急性硬膜下血肿患者。
- 采用受试者工作特征(ROC)分析并进行内部验证,确定将患者分为减压不充分组和良好颅内压组的颅内压阈值。
- 对住院结局和长期结局均进行多变量分析。
主要发现
- 确定的颅内压阈值为10 mmHg,特异性91.5%,敏感性45.7%,阳性预测值80.8%,阴性预测值68.4%。
- 减压不充分组26例(24.8%),良好颅内压组79例(75.2%)。
- 调整后,减压不充分组与术后甘露醇使用增加相关(OR 14.2,p < 0.001),与巴比妥类使用增加相关(OR 150,p = 0.001)。
- 减压不充分组与住院死亡率增加相关(OR 24.9,p < 0.001),与1年良好MRS率降低相关(OR 0.08,p = 0.008)。
- 两组并发症率相似。
关键数值与推荐
- 关颅时颅内压阈值10 mmHg:特异性91.5%,敏感性45.7%,阳性预测值80.8%,阴性预测值68.4%。
- 减压不充分组(26例,24.8%)vs 良好颅内压组(79例,75.2%)。
- 减压不充分组术后甘露醇使用OR 14.2(p < 0.001),巴比妥类使用OR 150(p = 0.001)。
- 减压不充分组住院死亡率OR 24.9(p < 0.001),1年良好MRS率OR 0.08(p = 0.008)。
临床怎么用
- 作者认为关颅时颅内压是与住院和长期结局相关的客观术中生物标志物。
- 作者指出可采取多种手术操作安全达到该颅内压目标。
- 作者建议开展大规模前瞻性研究验证该颅内压阈值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Acute subdural haematoma (ASDH) is associated with severe traumatic brain injury and poor outcomes. Although guidelines exist for the decompression of ASDH, the question of adequate decompression remains unanswered. The authors examined the relationship of intracranial pressure (ICP) on closure with outcomes to determine its utility in the determination of adequate ASDH decompression. METHODS: A multicentre retrospective review of 105 consecutive patients with ASDH who underwent decompressive surgery was performed. Receiver operating characteristic (ROC) analysis with internal validation was performed to determine an ICP threshold for the division of patients into the inadequate and good ICP groups. Multivariable analyses were performed for both inpatient and long-term outcomes. RESULTS: An ICP threshold of 10 mmHg was identified with a 91.5% specificity, 45.7% sensitivity, and a positive and negative predictive value of 80.8% and 68.4%. There were 26 patients (24.8%) and 79 patients (75.2%) in the inadequate and good ICP groups, respectively. After adjustment, the inadequate ICP group was associated with increased postoperative usage of mannitol (OR 14.2, p < 0.001) and barbiturates (OR 150, p = 0.001). Inadequate ICP was also associated with increased inpatient mortality (OR 24.9, p < 0.001), and a lower rate of favourable MRS at 1 year (OR 0.08, p = 0.008). The complication rate was similar amongst the groups. CONCLUSIONS: Closure ICP is a novel, objective, and actionable intraoperative biomarker that correlates with inpatient and long-term outcomes in ASDH. Various surgical manoeuvres can be undertaken to achieve this target safely. Large-scale prospective studies should be performed to validate this ICP threshold.
引用
- Lim JX, Liu SJ, Cheong TM, et al. Closure intracranial pressure is an objective intraoperative determinant of the adequacy of surgical decompression in traumatic acute subdural haematoma: a multicentre observational study. Acta Neurochir (Wien). 2022. PMID: 35831725. doi:10.1007/s00701-022-05270-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。